Dane Leone

Stock Analyst at Raymond James

(0)
# 3465
Out of 5,218 analysts
128
Total ratings
32.65%
Success rate
0.61%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
Xilio Therapeutics
Maintains: Outperform
6 4
0.98 308.16% 3 Nov 8, 2024
Regenxbio
Reinstates: Outperform
45
8.27 444.14% 2 Feb 21, 2024
Blueprint Medicines
Maintains: Strong Buy
85 100
93.28 7.2% 9 Dec 22, 2023
Revolution Medicines
Initiates Coverage On: Outperform
30
44.99 -33.32% 1 Nov 16, 2023
bluebird bio
Maintains: Outperform
200 260
6.36 3988.05% 6 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
950
730.7 30.01% 10 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 9
n/a n/a 3 Oct 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
13
2.35 453.19% 5 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
29 46
27.5 67.27% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
69
26.76 157.85% 5 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 8
n/a n/a 5 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
29
4.68 519.66% 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 8
1.46 447.95% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 14
8.67 61.48% 5 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
58
24.05 141.16% 4 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 70
30.88 126.68% 3 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 63
48.66 29.47% 2 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Apr 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 6
n/a n/a 2 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
52.62 23.53% 3 Oct 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Dec 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
255
270.45 -5.71% 3 Oct 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 5 Dec 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
32
6.25 412% 2 Sep 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Jul 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 3 Jun 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 Dec 22, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
n/a n/a 1 Sep 23, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 7, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Sep 5, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Aug 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 2 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 15, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Aug 11, 2016